The present invention relates to muteins of hNGF, their therapeutic uses and pharmaceutical compositions. In particular, the muteins o f the invention are selectively recognised by a specific reagent with regard to endogenous hNGF. The muteins are obtained by at least one amino acid substitution residing in loop III of hNGF.

Muteins of hNGF, therapeutic uses and pharmaceutical compositions

CAPSONI, Simona;
2006

Abstract

The present invention relates to muteins of hNGF, their therapeutic uses and pharmaceutical compositions. In particular, the muteins o f the invention are selectively recognised by a specific reagent with regard to endogenous hNGF. The muteins are obtained by at least one amino acid substitution residing in loop III of hNGF.
2006
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2350173
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact